Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling

Platinum-based regimens have been routinely used in the clinical treatment of patients with esophageal squamous cell carcinoma (ESCC). However, administration of these drugs is frequently accompanied by drug resistance. Revealing the underlying mechanisms of the drug resistance and developing agents...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cell Dev Biol
Main Authors: Cui, Wei, Fang, Tingting, Duan, Zhaoheng, Xiang, Dongfang, Wang, Yanxia, Zhang, Mengsi, Zhai, Fangzheng, Cui, Xiang, Yang, Lang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Cell and Developmental Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7758349/
https://ncbi.nlm.nih.gov/pubmed/33363149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.596788
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados